Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
- PMID: 27433341
- PMCID: PMC4876141
- DOI: 10.1002/prp2.231
Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Abstract
Fluoxetine is a selective serotonin uptake inhibitor that has been widely used to determine the neurotransmission of serotonin in the central nervous system. This substance has emerged as the drug of choice for the treatment of depression due to is safer profile, fewer side effects, and greater tolerability. Studies have found the following important functions of fluoxetine related to the central nervous system: neuroprotection; anti-inflammatory properties similar to standard drugs for the treatment of inflammatory conditions; antioxidant properties, contributing to its therapeutic action and an important intracellular mechanism underlying the protective pharmacological effects seen in clinical practice in the treatment of different stress-related adverse health conditions; and antiapoptotic properties, with greater neuron survival and a reduction in apoptosis mediators as well as oxidative substances, such as superoxide dismutase and hydrogen peroxide. The aim of this study was to perform a review of the literature on the important role of fluoxetine in anti-inflammatory, cell survival, and neuron trophicity mechanisms (antiapoptotic properties) as well as its role regarding enzymes of the antioxidant defense system.
Keywords: Antiapoptotic; Fluoxetine; antioxidant; anti‐inflammatory.
References
-
- Abdel‐Salam OME, Baiumoy AR, Arbid M (2004). Studies on the anti‐inflammatory effect of fluoxetine in the rat. Pharmacol Res 49: 119–131. - PubMed
-
- Agostinho FR, Scaini G, Ferreira GK, Jeremias IC, Réus GZ, Rezin GT, et al. (2009). Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain. Brain Res Bull 80: 337–340. - PubMed
-
- Agostinho FR, Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Benedet J, et al. (2011a). Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain. Neurosci Lett 487: 278–281. - PubMed
-
- Agostinho FR, Réus GZ, Stringari RB, Ribeiro KF, Ferreira GK, Jeremias IC, et al. (2011b). Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain. Acta Neuropsychiatr 23: 282–291. - PubMed
-
- Bai O, Zhang H, Li XM (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl‐2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010: 81–86. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
